EP 4169947 A1 20230426 - ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF
Title (en)
ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF
Title (de)
ANTI-CLAUDIN18.2-ANTIKÖRPER UND VERWENDUNG DAVON
Title (fr)
ANTICORPS ANTI-CLAUDINE 18.2 ET SON UTILISATION
Publication
Application
Priority
- CN 202010570517 A 20200619
- CN 2021100870 W 20210618
Abstract (en)
The present invention relates to a novel antibody and an antibody fragment that specifically bind to Claudin18.2 and a composition comprising the antibody or the antibody fragment. In addition, the present invention relates to a nucleic acid encoding the antibody or the antibody fragment thereof, a host cell comprising the nucleic acid, and related uses. Furthermore, the present invention relates to therapeutic and diagnostic uses of the antibody and the antibody fragment.
IPC 8 full level
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)
CPC (source: EP KR US)
A61K 39/3955 (2013.01 - US); A61K 45/06 (2013.01 - US); A61K 47/6803 (2017.08 - KR); A61P 1/18 (2018.01 - US); A61P 35/00 (2018.01 - EP KR US); A61P 35/02 (2018.01 - EP); C07K 16/28 (2013.01 - EP KR US); G01N 33/57438 (2013.01 - US); A61K 2039/505 (2013.01 - EP KR US); A61K 2039/545 (2013.01 - EP); C07K 2317/21 (2013.01 - EP); C07K 2317/24 (2013.01 - EP US); C07K 2317/33 (2013.01 - EP); C07K 2317/732 (2013.01 - EP KR US); C07K 2317/734 (2013.01 - EP KR US); C07K 2317/92 (2013.01 - EP KR US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
EP 4169947 A1 20230426; AU 2021291259 A1 20230119; CA 3178855 A1 20211223; CN 115943162 A 20230407; JP 2023530003 A 20230712; KR 20230023664 A 20230217; TW 202204416 A 20220201; TW I809426 B 20230721; US 2023235047 A1 20230727; WO 2021254481 A1 20211223; WO 2021254481 A9 20220217
DOCDB simple family (application)
EP 21827108 A 20210618; AU 2021291259 A 20210618; CA 3178855 A 20210618; CN 2021100870 W 20210618; CN 202180043345 A 20210618; JP 2022577518 A 20210618; KR 20227045059 A 20210618; TW 110122381 A 20210618; US 202118010944 A 20210618